Scilex Holding Co (SCLX)
1.145
+0.04
(+3.15%)
USD |
NASDAQ |
May 22, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
Scilex Total Return Price: 1.145 for May 22, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 21, 2024 | 1.11 |
| May 20, 2024 | 1.21 |
| May 17, 2024 | 0.90 |
| May 16, 2024 | 0.87 |
| May 15, 2024 | 0.8183 |
| May 14, 2024 | 0.80 |
| May 13, 2024 | 0.8049 |
| May 10, 2024 | 0.7454 |
| May 09, 2024 | 0.8302 |
| May 08, 2024 | 0.8471 |
| May 07, 2024 | 0.9173 |
| May 06, 2024 | 0.8655 |
| May 03, 2024 | 0.86 |
| May 02, 2024 | 0.8484 |
| May 01, 2024 | 0.8556 |
| April 30, 2024 | 0.8532 |
| April 29, 2024 | 0.9221 |
| April 26, 2024 | 0.8805 |
| April 25, 2024 | 0.8608 |
| April 24, 2024 | 0.85 |
| April 23, 2024 | 0.9767 |
| April 22, 2024 | 0.9514 |
| April 19, 2024 | 0.8978 |
| April 18, 2024 | 0.90 |
| April 17, 2024 | 1.17 |
| Date | Value |
|---|---|
| April 16, 2024 | 1.16 |
| April 15, 2024 | 1.28 |
| April 12, 2024 | 1.33 |
| April 11, 2024 | 1.30 |
| April 10, 2024 | 1.34 |
| April 09, 2024 | 1.36 |
| April 08, 2024 | 1.39 |
| April 05, 2024 | 1.53 |
| April 04, 2024 | 1.53 |
| April 03, 2024 | 1.54 |
| April 02, 2024 | 1.55 |
| April 01, 2024 | 1.57 |
| March 28, 2024 | 1.59 |
| March 27, 2024 | 1.61 |
| March 26, 2024 | 1.51 |
| March 25, 2024 | 1.46 |
| March 22, 2024 | 1.44 |
| March 21, 2024 | 1.40 |
| March 20, 2024 | 1.36 |
| March 19, 2024 | 1.35 |
| March 18, 2024 | 1.37 |
| March 15, 2024 | 1.37 |
| March 14, 2024 | 1.39 |
| March 13, 2024 | 1.33 |
| March 12, 2024 | 1.32 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.7454
Minimum
May 10 2024
14.80
Maximum
Apr 12 2023
4.238
Average
3.25
Median
Dec 16 2022
Total Return Price Benchmarks
| Sorrento Therapeutics Inc | 0.011 |
| Adial Pharmaceuticals Inc | 1.39 |
| Precision BioSciences Inc | 12.97 |
| Humacyte Inc | 7.56 |
| Perspective Therapeutics Inc | 1.485 |